Racial and socioeconomic disparities in survival among patients with metastatic non–small cell lung cancer
Dipesh Uprety(The Barbara Ann Karmanos Cancer Institute), Ann G. Schwartz(The Barbara Ann Karmanos Cancer Institute), Tarik Hadid(Wayne State University), Hirva Mamdani(Wayne State University), Julie J. Ruterbusch(Wayne State University), Randell Seaton(Wayne State University), Ammar Sukari(The Barbara Ann Karmanos Cancer Institute)
Cited by 14
Related Papers
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
|Journal of Clinical Oncology|2017|653
Immunotherapy in Lung Cancer: Current Landscape and Future Directions
|Frontiers in Immunology|2022|373
Trends in short-term survival from distant-stage cutaneous melanoma in the United States, 2001-2013 (CONCORD-3)
|JNCI Cancer Spectrum|2020|163
Familial Aggregation of Common Sequence Variants on 15q24-25.1 in Lung Cancer
|JNCI Journal of the National Cancer Institute|2008|152
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline
|Journal of Clinical Oncology|2022|125